NCT06025097View on ClinicalTrials.gov

Intra-Tympanic Steroid With PRP Combination in Sensorineural Hearing Loss and Tinnitus.

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

September 30, 2023

Study Completion Date

October 21, 2023

Conditions
Sensorineural Hearing LossTinnitus
Interventions
DRUG

Combination Solution

Methyl Prednisone (Trade name: SOLU-MEDROL) + Platelet rich Plasma (Autologous Biological product) via intra-tympanic rout about 1-1.5 ml.

Trial Locations (1)

75700

Combined Military Hospital, Rawalpindi

All Listed Sponsors
lead

CMH RWP Combined Military Hospital RWP: Rawalpindi

OTHER_GOV

NCT06025097 - Intra-Tympanic Steroid With PRP Combination in Sensorineural Hearing Loss and Tinnitus. | Biotech Hunter | Biotech Hunter